ALR Technologies Inc.

ALR Technologies Inc. ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases.

ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website. Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their quality goals. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.

"Worldwide, diabetes rates nearly doubled, from 4.7 percent in 1980 to 8.5 percent in 2014. Roughly one in 12 people liv...
04/08/2016

"Worldwide, diabetes rates nearly doubled, from 4.7 percent in 1980 to 8.5 percent in 2014. Roughly one in 12 people living in the world today have the disease, which has spread dramatically."

The World Health Organization's first global report on diabetes says the disease's dramatic spread has disproportionately affected low- and middle-income countries.

ALRT helps improve adherence in the most challenging diabetes patients
03/29/2016

ALRT helps improve adherence in the most challenging diabetes patients

Diabetes is a silent disease—most of these patients feel fine, even if their sugar levels are dangerously high. Because they don’t feel ill, many diabetic patients aren’t motivate

ALRT is squarely positioned in each of the disruptive business models
03/22/2016

ALRT is squarely positioned in each of the disruptive business models

As the healthcare industry is being disrupted, four new business models with fundamentally different economics are forming in and around the pharmaceutical a...

"Tele-behavioral treatment led to improvements in depression, anxiety, stress, self-management, and glucose levels in pa...
03/15/2016

"Tele-behavioral treatment led to improvements in depression, anxiety, stress, self-management, and glucose levels in patients with diabetes."

Marie ThibaultCompanies delivering healthcare in new ways are receiving plenty of attention for their potential to save time and money. Many of these companies are trying to prove the benefits of their novel delivery methods and the effectiveness of the healthcare delivered. AbilTo, a company that o…

"Integrated approaches using electronic health records, clinical decision support, and patient-controlled technologies m...
03/14/2016

"Integrated approaches using electronic health records, clinical decision support, and patient-controlled technologies may help improve the appropriate use of medication as well as the management of type 2 diabetes."

03/08/2016

We’re in the business of improving health outcomes for patients with diabetes.

No need to do it yourself.  ALRT will do it for you accurately and affordably.
03/08/2016

No need to do it yourself. ALRT will do it for you accurately and affordably.

Parents of children with diabetes have led an egalitarian push for improved technology to monitor the condition, and to even develop cheaper insulin.

ALRT doesn't overlay technology on a doctor's busy day -- it saves you time so you can focus on the things that count.
03/02/2016

ALRT doesn't overlay technology on a doctor's busy day -- it saves you time so you can focus on the things that count.

EHR's suck. Let's make 'em better. Go to http://LetDoctorsBeDoctors.com and tell the IT and government folks what's up. And check out http://zdoggmd.com for ...

Can Big Data Fix Healthcare? The Case for mHealth and Chronic Disease
02/26/2016

Can Big Data Fix Healthcare? The Case for mHealth and Chronic Disease

02/19/2016

Between 40% & 60% of type2 diabetes patients fabricate blood glucose results and 18% fail to record anything at all. ALRT readings are based on real data. No fudging possible.

1. The Centers for Disease Control and Prevention. National diabetes fact sheet: National estimates and general information on diabetes in the United States. Revised edition. Atlanta, GA, US Department of Health and Human Services, Centers for Disease Control and Prevention, 1998.

Patients with T2D benefit most from individualized treatment plans; however, time limitations of health care providers a...
02/10/2016

Patients with T2D benefit most from individualized treatment plans; however, time limitations of health care providers are a significant barrier to successful individualization and care coordination. Patients are often left with unanswered questions, a lack of motivation, and confusion about their disease. If patients do not understand the disease and its possible long-term effects, they are less likely to adhere to their treatment plans.

Poor medication adherence is responsible for unnecessary illness, hospitalizations, disability, and premature death, particularly among patients with chronic diseases.

Address

7400 Beaufont Springs Drive Ste 300
Richmond, VA
23225

Alerts

Be the first to know and let us send you an email when ALR Technologies Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram